8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2018 / Randomized crossover trial
In a crossover trial, 14 healthy volunteers in Mali tested gastric emptying rates of eight starchy staples using a carbon-13 octanoic acid breath test, followed by a 6-volunteer validation study. Traditional sorghum and millet foods showed gastric half-emptying times approximately twice as long as white rice, potato, or pasta (p < 0.0001). Pre-test assessments ranked millet couscous and rice as more filling, aligning with postprandial hunger ratings.
Cisse F, Erickson DP, Hayes AMR, et al. Nutrients, 2018. PMID 29373493
2018 / Parallel-design randomized controlled trial
Forty-two normal-weight healthy short sleepers were randomized to a sleep extension group receiving a sleep hygiene behavioral consultation (n = 21) or a control group maintaining habitual short sleep (n = 21) for 4 weeks. Compared with controls, the sleep extension group significantly increased time in bed (0:55 h:mm), sleep period (0:47 h:mm), and sleep duration (0:21 h:mm). Sleep extension led to a significant reduction in free sugar intake (-9.6 g vs. 0.7 g in controls; P = 0.042), with no significant differences observed between groups in markers of energy balance or cardiometabolic health.
Al Khatib HK, Hall WL, Creedon A, et al. Am J Clin Nutr, 2018. PMID 29381788
2018 / Randomized controlled trial
A randomized, double-blind, placebo-controlled trial evaluated d-allulose at 4 g or 7 g twice daily against sucralose in 121 Korean adults with BMI ≥ 23 kg/m². Body fat percentage and body fat mass decreased following allulose supplementation. Compared with placebo, the high-dose group demonstrated significant reductions in BMI along with total abdominal and subcutaneous fat areas on CT scans, with no differences in lipid profiles or nutrient intake.
Han Y, Kwon EY, Yu MK, et al. Nutrients, 2018. PMID 29385054
2018 / Randomized controlled trial
Thirty-seven adults with type 2 diabetes completed a 12-week trial testing two weekly very-low-calorie fasting days scheduled either consecutively (n=18) or non-consecutively (n=19). Fasting increased the risk of hypoglycaemia despite medication reduction (RR 2.05, 95% CI 1.17 to 3.52). However, hypoglycaemia rates did not differ significantly between consecutive and non-consecutive fasting regimens (RR 1.54, 95% CI 0.35 to 6.11).
Corley BT, Carroll RW, Hall RM, et al. Diabet Med, 2018. PMID 29405359
2018 / Randomized, placebo-controlled, double-blind parallel trial
In a double-blind trial, 44 sports-active adults were randomized to receive 400 mg lemon verbena extract (Recoverben®) daily or placebo for 15 days, which included 10 days pre-exercise, the day of an intensive jump protocol, and 4 days post-exercise. Compared to placebo, participants receiving lemon verbena extract experienced significantly less exercise-related loss of muscle strength over all timepoints (p = 0.0311). They also showed a trend toward improved glutathione peroxidase activity (p = 0.0681) and less movement-induced pain (p = 0.0788), whereas creatine kinase and IL-6 did not differ significantly between groups.
Buchwald-Werner S, Naka I, Wilhelm M, et al. J Int Soc Sports Nutr, 2018. PMID 29410606
2018 / Open-label, non-randomized, controlled study
An open-label, non-randomized controlled study evaluated a 1-year continuous care intervention (CCI) delivering remote care, biometric feedback, and nutritional ketosis versus usual care (UC) in adults with type 2 diabetes. In the CCI group, HbA1c declined from 7.6 ± 0.09% to 6.3 ± 0.07%, weight decreased by 13.8 ± 0.71 kg, and non-metformin diabetes medication prescriptions fell from 56.9 ± 3.1% to 29.7 ± 3.0% (all P < 1.0 × 10^-16). Insulin was reduced or stopped in 94% of users, sulfonylureas were eliminated, and improvements were observed in HOMA-IR, hsCRP, and triglycerides, alongside a 10% increase in LDL-C; usual care participants had no significant biomarker or medication changes.
Hallberg SJ, McKenzie AL, Williams PT, et al. Diabetes Ther, 2018. PMID 29417495
2018 / Randomized controlled trial
Overweight or obese adults were randomized to an 8-week caloric restriction diet alone (CR, n = 15) or combined with sleep restriction on 5 nights per week (CR + SR, n = 21). Both groups had similar total weight, lean mass, and fat mass loss. However, the proportion of total mass lost as fat was significantly greater in the CR group (p = 0.016). Resting respiratory quotient decreased only in CR (p = 0.033), and fasting leptin concentration decreased only in CR + SR (p = 0.029).
Wang X, Sparks JR, Bowyer KP, et al. Sleep, 2018. PMID 29438540
2018 / Repeated-measures test-retest trial
Eleven participants completed two 24-hour fasts following a 3-day standardized weight-maintenance diet to evaluate test-retest reliability of hunger variables and subsequent energy intake. At 16 hours of fasting, ICCs for all hunger-related assessments were significant (r = 0.67-0.91; p ≤ 0.05), but reliability varied over time, with average ICCs of 0.81 for fullness, 0.74 for prospective food consumption (PFC), 0.67 for energy, 0.44 for desire to eat (DTE), and 0.36 for hunger. Average post-fast energy compensation was 60% of weight-maintenance needs (ranging 7 to 110%) and correlated with changes in PFC, hunger, and DTE, but not body fat percentage. After fasting, percent energy intake from fat and protein increased (29.9% to 37.3% and 13.8% to 16.8%), while carbohydrate intake decreased (56.4% to 46.0%).
Tinsley GM, Moore ML, Graybeal AJ Physiol Behav, 2018. PMID 29438660
2018 / Randomized controlled pilot study
An 8-week randomized controlled pilot study examined the impact of energy distribution timing within a hypocaloric, three-meal diet in 8 participants. Participants were assigned to either a Morning pattern (50%, 30%, and 20% of kcal at breakfast, lunch, and dinner) or an Evening pattern (20%, 30%, and 50% of kcal at breakfast, lunch, and dinner). Percent weight loss and regularity of sleep onset and wake times were significantly greater for Morning compared to Evening (p < 0.05). The authors note the need for longer studies in free-living participants with time-stamped dietary assessments.
Raynor HA, Li F, Cardoso C Physiol Behav, 2018. PMID 29471076
2018 / Randomized trial
Twenty-seven overweight or obese adults were randomized to intermittent energy restriction (IER, n=15) or continuous energy restriction (CER) until achieving 5% weight loss, followed by 7 days of weight stabilization. There was no significant difference in time to 5% weight loss (median 59 d vs 73 d, P=0.246) or body composition changes between groups. Neither diet significantly altered postprandial glycaemia (P=0.266), and insulinaemia was reduced comparatively (P=0.903). However, IER led to a significantly greater relative reduction in postprandial TAG responses (106 to 68 mmol×360 min/l) compared to CER (117 to 130 mmol×360 min/l; P=0.045), and a trend toward a greater reduction in C-peptide (P=0.057).
Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2018. PMID 29508693
2018 / Randomized controlled crossover trial
In a randomized, double-blind trial, 101 male athletes completed a 10-km cycling time trial with 0, 2, or 4 mg/kg of caffeine. Overall, 4 mg/kg decreased cycling duration by 3% versus placebo (P = 0.01), but a significant caffeine-gene interaction occurred (P < 0.0001). Cycling time decreased at 2 mg/kg (-4.8%) and 4 mg/kg (-6.8%) in AA genotypes, showed no change in AC genotypes, and lengthened by 13.7% at 4 mg/kg in CC genotypes.
Guest N, Corey P, Vescovi J, et al. Med Sci Sports Exerc, 2018. PMID 29509641
2018 / Randomized controlled trial
Participants were randomly assigned to consume two kiwifruits per day for 5 months or no kiwifruit, with initial periodontal treatment (IPT) delivered at 2 months. At 2 months prior to IPT, bleeding score decreased significantly within the kiwifruit group by 6.67% ± 11.90% (P < 0.01), and the kiwifruit group had significantly lower values of bleeding, plaque, and attachment loss compared to controls. After IPT at 5 months, both groups demonstrated clinical benefits, but the control group had significantly greater reductions of bleeding, plaque, and attachment loss than the test group. Systemic biomarkers and vital signs showed no clinically relevant differences between groups.
Graziani F, Discepoli N, Gennai S, et al. J Periodontol, 2018. PMID 29520772
2018 / Double-blind, randomized, placebo-controlled trial
A double-blind, randomized, placebo-controlled trial evaluated the efficacy of Amla (Phyllanthus emblica L.) tablets in 68 patients with non-erosive reflux disease. Participants took two 500 mg Amla tablets or placebo twice daily after meals for 4 weeks. Heartburn and regurgitation frequencies significantly dropped in both groups (P < 0.001), but repeated measures logistic regression demonstrated a significantly greater reduction in the frequency and severity of both heartburn and regurgitation in the Amla group compared to placebo (P < 0.001).
Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. J Integr Med, 2018. PMID 29526236
2018 / Randomized clinical trial (2x2 factorial)
A 2x2 factorial randomized trial assigned 92 functionally limited older men for 6 months to controlled diets of 0.8 or 1.3 g/kg/d of protein, paired with weekly testosterone or placebo. Changes in lean body mass (0.31 kg; 95% CI, -0.46 to 1.08 kg; P = .43), appendicular lean mass, muscle strength, physical function, and well-being did not differ between protein levels, regardless of testosterone use. However, fat mass decreased significantly more with higher protein intake compared to the RDA group (difference, -1.12 kg; 95% CI, -2.04 to -0.21; P = .02).
Bhasin S, Apovian CM, Travison TG, et al. JAMA Intern Med, 2018. PMID 29532075
2018 / Within-subject comparative study with washout
Ten patients with type 2 diabetes completed a 10-day supervised peri-operative-equivalent diet intervention, followed by a washout period, and then an identical diet paired with RYGB. Both interventions produced similar improvements in glucose levels, β-cell function, insulin sensitivity, and post-meal hepatic insulin resistance, alongside significant decreases in fasting and postprandial acyl ghrelin. The diet-only period led to greater improvements in basal hepatic glucose output and post-meal GIP secretion, whereas the diet plus RYGB intervention induced significantly greater increases in post-meal GLP-1, PYY, and glucagon levels.
Pop LM, Mari A, Zhao TJ, et al. Diabetes Obes Metab, 2018. PMID 29532631
2018 / Double-blind, crossover, randomized, placebo-controlled trial
In a randomized, double-blind crossover trial, 22 older adults with abdominal obesity underwent a 6-hour oral fat tolerance test after consuming either a supplement (200 mg resveratrol and 100 mg curcumin) or a placebo. Supplementation did not modify postprandial variations in circulating inflammatory markers (CRP, IL-6, IL-8, MCP-1) or adhesion molecules (sE-selectin, sVCAM-1, sICAM-1) compared to placebo (P Treatment×Time > 0.05). However, the supplement significantly reduced the cumulative postprandial response of sVCAM-1 (incremental area under the curve -4643%, P = 0.01), while whole-blood PPARA and NFKB1 gene expressions were unchanged.
Vors C, Couillard C, Paradis ME, et al. J Nutr, 2018. PMID 29546309
2018 / Double-blind, randomized crossover trial
A double-blind, randomized crossover trial evaluated the effects of 16 mg daily of TA-65 (an Astragalus membranaceus extract) versus placebo for 12 weeks with a 3-week washout in 40 patients with metabolic syndrome. Compared to placebo, TA-65 treatment led to significantly higher HDL-C and lower BMI, waist circumference, LDL/HDL ratio, and plasma TNF-alpha (p < 0.05 for all). Changes in HDL-C between periods were negatively correlated with changes in CRP (r = -0.511, p < 0.01), ALT (r = -0.61, p < 0.001), and TNF-alpha (r = -0.550, p < 0.001).
Fernandez ML, Thomas MS, Lemos BS, et al. Curr Pharm Des, 2018. PMID 29546832
2018 / Randomized controlled trial
Forty omnivorous women followed a control omnivorous diet, an unsupplemented vegetarian diet, or a vegetarian diet with creatine and beta-alanine for six months. Plasma and muscle total creatine dropped significantly by three months in unsupplemented vegetarians, whereas plasma creatine increased in supplemented vegetarians. Dietary changes did not affect carnitine-related measures or unsupplemented muscle carnosine, showing that low-dose creatine supplementation ameliorated the vegetarian-induced decline in the creatine pool.
Blancquaert L, Baguet A, Bex T, et al. Br J Nutr, 2018. PMID 29569535
2018 / Uncontrolled before-and-after intervention study
Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).
Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002
2018 / Randomized controlled trial
A randomized trial assigned 53 non-obese adults to either approximately 15% calorie restriction (n = 34) or a control group (n = 19) for two years. Participants in the restriction group lost an average of 8.7 kg, while control participants gained 1.8 kg. Measured daily energy expenditure was 80 to 120 kcal lower than predicted from weight loss, accompanied by decreased thyroid axis activity and lower F2-isoprostane levels.
Redman LM, Smith SR, Burton JH, et al. Cell Metab, 2018. PMID 29576535
2018 / Randomized controlled trial
Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.
Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220
2018 / Randomized controlled trial
Forty patients with Hashimoto's thyroiditis aged 22-50 were randomized to receive powdered Nigella sativa or placebo daily for 8 weeks. Treatment with Nigella sativa significantly reduced body weight and body mass index, decreased serum LDL and triglyceride concentrations, and significantly increased HDL cholesterol (P < 0.05), while no such changes were seen in the placebo group. Serum Nesfatin-1 was inversely associated with triglycerides (r = -0.31, P = 0.04).
Farhangi MA, Dehghan P, Tajmiri S Lipids Health Dis, 2018. PMID 29587770
2018 / Randomized clinical study
A randomized clinical study of specifically designed isoenergetic diets paired with fecal shotgun metagenomics evaluated the effect of dietary fibers in patients with type 2 diabetes mellitus. Dietary fibers selectively promoted a specific group of short-chain fatty acid (SCFA)-producing strains while diminishing or leaving unchanged most other potential producers. Greater diversity and abundance of these fiber-promoted SCFA producers led to greater improvements in hemoglobin A1c levels, partly through increased glucagon-like peptide-1 production, and diminished bacteria producing detrimental compounds like indole and hydrogen sulfide.
Zhao L, Zhang F, Ding X, et al. Science, 2018. PMID 29590046
2018 / 2 x 6-week randomized, double-blind, placebo-controlled crossover trial
In a 2 x 6-week randomized, double-blind, placebo-controlled crossover clinical trial, researchers assessed the effects of chronic supplementation with the NAD+ precursor nicotinamide riboside (NR) in healthy middle-aged and older adults. Chronic NR supplementation was well tolerated and effectively stimulated NAD+ metabolism. The results suggest that future clinical trials should further evaluate the potential benefits of NR for reducing blood pressure and arterial stiffness in this population.
Martens CR, Denman BA, Mazzo MR, et al. Nat Commun, 2018. PMID 29599478